214 related articles for article (PubMed ID: 20692493)
1. Transcranial sonography in relation to SPECT and MIBG.
Kajimoto Y; Miwa H; Kondo T
Int Rev Neurobiol; 2010; 90():48-62. PubMed ID: 20692493
[TBL] [Abstract][Full Text] [Related]
2. Imaging neurodegeneration in Parkinson's disease.
Pavese N; Brooks DJ
Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
[TBL] [Abstract][Full Text] [Related]
3. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
[TBL] [Abstract][Full Text] [Related]
4. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
Izawa MO; Miwa H; Kajimoto Y; Kondo T
Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
6. Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease.
Kajimoto Y; Miwa H; Okawa-Izawa M; Hironishi M; Kondo T
Parkinsonism Relat Disord; 2009 May; 15(4):270-2. PubMed ID: 18691928
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of transcranial sonographic findings and MIBG cardiac scintigraphy in the diagnosis of idiopathic Parkinson's disease.
Behnke S; Hellwig D; Bürmann J; Runkel A; Farmakis G; Kirsch CM; Fassbender K; Becker G; Dillmann U; Spiegel J
Parkinsonism Relat Disord; 2013 Nov; 19(11):995-9. PubMed ID: 23880025
[TBL] [Abstract][Full Text] [Related]
8. On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.
Odagiri H; Baba T; Nishio Y; Iizuka O; Matsuda M; Inoue K; Kikuchi A; Hasegawa T; Aoki M; Takeda A; Taki Y; Mori E
PLoS One; 2016; 11(4):e0152746. PubMed ID: 27055151
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Parkinson's disease--transcranial sonography in relation to MRI.
Niehaus L; Boelmans K
Int Rev Neurobiol; 2010; 90():63-79. PubMed ID: 20692494
[TBL] [Abstract][Full Text] [Related]
10. Transcranial sonography in the premotor diagnosis of Parkinson's disease.
Behnke S; Schröder U; Berg D
Int Rev Neurobiol; 2010; 90():93-106. PubMed ID: 20692496
[TBL] [Abstract][Full Text] [Related]
11. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.
Walter U
Expert Rev Neurother; 2009 Jun; 9(6):835-46. PubMed ID: 19496687
[TBL] [Abstract][Full Text] [Related]
12. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging of rapid eye movement sleep behavior disorder: transcranial ultrasound, single-photon emission computed tomography, and positron emission tomography scan data.
Miyamoto M; Miyamoto T
Sleep Med; 2013 Aug; 14(8):739-43. PubMed ID: 23648146
[TBL] [Abstract][Full Text] [Related]
14. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
[TBL] [Abstract][Full Text] [Related]
15. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.
Walter U
J Neural Transm (Vienna); 2011 Apr; 118(4):607-12. PubMed ID: 21190047
[TBL] [Abstract][Full Text] [Related]
16. Early diagnosis of Parkinson's disease.
Gaenslen A; Berg D
Int Rev Neurobiol; 2010; 90():81-92. PubMed ID: 20692495
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
18. [Transcranial sonography of substantia nigra in patients with Parkinson's disease].
Miwa H
Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans.
Liu P; Li X; Li FF; Ou-Yang QH; Zhang HX; Feng T
Neurosci Lett; 2014 Oct; 582():99-103. PubMed ID: 25218716
[TBL] [Abstract][Full Text] [Related]
20. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
